News
Novo Nordisk (NVO) makes Ozempic, the best-known GLP-1 drug out today. And until quite recently, the Danish pharma giant ...
The report also underscored the importance of maintaining muscle mass and bone density while losing weight. Since weight loss ...
Poison control experts say calls related to GLP-1 weight-loss drugs like Wegovy and Zepbound are rising, with symptoms like ...
The percentage of overweight or obese adults prescribed GLP-1s jumped by almost 587% between 2019 and 2024, according to a ...
The percentage of adults prescribed a GLP-1 drug like Wegovy or Zepbound jumped almost sevenfold over the past five years, ...
Many folks in NC can’t access Ozempic due to limited insurance coverage. But policy changes and falling prices may expand access soon.
After the slimming effect of Ozempic and Zepbound earned billions for Novo Nordisk and Eli Lilly, another class of ...
Lizzo has explained why she won’t reveal the exact amount of weight she has lost. Despite her right to privacy, the singer’s ...
Explore the evolving landscape of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) for obesity, highlighting access ...
Drugmakers are offering the blockbuster medications at steep discounts to people willing to pay out of pocket.
The health AI "super app" wants to add more nutrition data to its platform with this buy, its second acquisition of the yar.
FRANKFURT, Germany (AP) — Danish pharmaceutical company Novo Nordisk A/S, maker of blockbuster weight loss ... New England Journal of Medicine showing people lost more weight using competitor ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results